Titan Medical Inc. (T:TMD)
Business Focus: Biotechnology & Medical Research
| Sector: Healthcare | Industry: Biotechnology & Medical Research |
| See Regulatory Filings on SEDAR | |
| Company Contact | |
| Address: | 170 University Ave TORONTO ON M5H 3B3 |
| Tel: | N/A |
| Website: | https://www.titanmedicalinc.com |
| IR: | See website |
| Key People | ||
| David J. McNally Chairman of the Board, President, Chief Executive Officer | Monique L. Delorme Chief Financial Officer | Perry A. Genova Senior Vice President - Research and Development |
| Sachin Sankholkar Vice President of Marketing | Curtis R. Jensen Vice President - Quality and Regulatory Affairs | Chris Seibert Vice President - Business Development |
| Business Overview |
| Titan Medical Inc. is focused on the development of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS) comprising its single-port robotic surgical system. The system under development includes a surgeon-controlled patient cart that includes a three dimension (3D) high definition vision system and multi-articulating instruments for performing MIS procedures and a surgeon workstation that provides the surgeon with an ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. It is developing its SPORT Surgical system as a versatile single incision advanced robotic surgical system that features multi-articulated instruments with single-use replaceable tips. It also features visualization on a flat-screen monitor and a single-arm mobile patient cart while enabling broad applications of a single and multi-quadrant surgeries. |
| Financial Overview |
| For the nine months ended 30 September 2020, TitanMedical Inc. revenues increased from $0K to $10M. Net lossdecreased 92% to $3.6M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Lower net loss reflectsResearch and development decrease of 95% to $2.4M (expense), Consulting fees decrease of 69% to $318K (expense), Stockbased compensation decrease of 49% to $721K (expense). |
| Employees: | 10 as of Dec 31, 2019 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $144.30M as of Sep 30, 2020 |
| Annual revenue (TTM): | $12.92M as of Sep 30, 2020 |
| EBITDA (TTM): | -$1.61M as of Sep 30, 2020 |
| Net annual income (TTM): | -$1.47M as of Sep 30, 2020 |
| Free cash flow (TTM): | -$4.21M as of Sep 30, 2020 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 82,184,843 as of Nov 16, 2020 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Company fundamental and
price data sourced from © Thomson Reuters Limited. All rights reserved. Republication or redistribution of
Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent
of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for
any actions taken in reliance on such content. 'Thomson Reuters' and the Thomson Reuters logo are trademarks of
Thomson Reuters and its affiliated companies. US Quotes data provided by IEX.
Interactive technical study charts by TradingView. Copyright © 2020 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.